Cargando…
Effects of signaling pathway inhibitors on hematopoietic stem cells
While there are numerous small molecule inhibitory drugs available for a wide range of signalling pathways, at present, they are generally not used in combination in clinical settings. Previous reports have reported that the effects of glycogen synthase kinase (GSK)3β, p38MAPK, mTOR and histone deac...
Autores principales: | Jiang, Yuyu, Xu, Zhaofeng, Ma, Na, Yin, Lizhi, Hao, Caiqin, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687261/ https://www.ncbi.nlm.nih.gov/pubmed/33179097 http://dx.doi.org/10.3892/mmr.2020.11647 |
Ejemplares similares
-
New paradigms on hematopoietic stem cell differentiation
por: Cheng, Hui, et al.
Publicado: (2019) -
Hematopoietic Stem Cell Development, Niches, and Signaling Pathways
por: Chotinantakul, Kamonnaree, et al.
Publicado: (2012) -
Cell Signaling Pathway Reporters in Adult Hematopoietic Stem Cells
por: de Roo, Jolanda. J.D., et al.
Publicado: (2020) -
Signal, Transduction, and the Hematopoietic Stem Cell
por: Louria-Hayon, Igal
Publicado: (2014) -
Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling
por: Li, Jing, et al.
Publicado: (2016)